Activation of the AKT/GSK-3β/β-catenin pathway via photobiomodulation therapy promotes neural stem cell proliferation in neonatal rat models of hypoxic-ischemic brain damage

Zhaoying Liao,Xuanzi Zhou,Siyu Li,Wei Jiang,Tingsong Li,Nanqing Wang,Nong Xiao,Zhaoying Liao,Xuanzi Zhou,Siyu Li,Wei Jiang,Tingsong Li,Nanqing Wang,Nong Xiao
DOI: https://doi.org/10.21037/atm-21-5619
IF: 3.616
2022-01-01
Annals of Translational Medicine
Abstract:Background: Hypoxic-ischemic brain damage (HIBD) significantly affects neurodevelopment in infants and is a leading cause of severe neurological morbidity and mortality in neonates. Our previous study found that photobiomodulation therapy (PBMT) improves the impaired spatial learning and memory of HIBD rat models. However, the neuroprotective mechanism conferred by PBMT in HIBD is unclear.Methods: In the present study, HIBD model rats were treated with PBMT at 5 mW/cm<sup>2</sup> per day in the dark for 14 days (10 min each day), and primary neural stem cells (NSCs) after oxygen-glucose deprivation (OGD) were treated with PBMT for 10 min at 1, 5, 10, and 20 mW/cm<sup>2</sup> in the dark. PBMT promoted hippocampal neural stem cell (NSC) proliferation <i>in vivo</i> and <i>in vitro</i>.Results: Mechanistically, PBMT upregulated phosphatidylinositol 3 kinase (PI3K), phosphorylated protein kinase B (p-AKT), phosphorylated glycogen synthase kinase 3 beta (p-GSK-3β), β-catenin, and cyclin D1 expression <i>in vivo</i> and <i>in vitro</i>, promoting NSC proliferation. Furthermore, both LY294002 (a PI3K inhibitor) and IWR-1 (a Wnt/β-catenin inhibitor) inhibited the PBMT promotion of NSC proliferation after OGD and suppressed β-catenin and cyclin D1 expression <i>in vitro</i>.Conclusions: PBMT improved the spatial learning and memory of HIBD rats and promoted hippocampal NSC proliferation through the AKT/GSK-3β/β-catenin pathway.
oncology,medicine, research & experimental
What problem does this paper attempt to address?